PacBio Announces Onso, the Highly Accurate Short-Read Sequencing Platform – QNT Press Release

The Onso Sequencing System is Designed to Deliver Industry-Leading Sensitivity and Specificity for Novel Insights in Oncology and Disease Research

MENLO PARK, Calif., Oct. 25, 2022 /PRNewswire/ — PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the commencement of external beta testing of the Onso™ sequencing system. This innovative benchtop short-read DNA sequencing platform is expected to provide an extraordinary level of accuracy by utilizing utilizing PacBio’s unique sequencing by binding (SBB) technology.

“We are excited to see how researchers will leverage the ground-breaking sequencing accuracy that we expect Onso to deliver. Upon the launch, we expect to become the only company that we know of to offer both highly accurate, native short- and long- read sequencing technologies, which will enable us to offer more complete solutions to our customers’ challenges,” said Christian HenryPresident and Chief Executive Officer of PacBio. “Onso is designed to deliver highly accurate sequencing reads, support scalable, flexible, and cost-optimized operation, and enable customers to feel more confident in their science. This system is designed to be a game changer for the genomics industry, and we’re excited to begin shipping beta systems to our beta partners.”

PacBio expects to begin taking orders for Onso in the first quarter of 2023 and expects to begin shipments of the system in the first half of 2023 upon completion of the external beta program. PacBio has chosen three beta testing sites for Onso: The Broad Institute of MIT and HarvardCorteva Agriscience, and Weill Cornell Medicine. Through the beta testing, scientists will be able to test Onso’s specifications and provide critical feedback to PacBio.

Onso has been designed for compatibility with the rich ecosystem of products currently available for short-read sequencers. It supports a diverse set of library preparation types, single-cell analysis solutions, and whole-genome sequencing and other targeted methods, such as amplicon and hybridization capture panels. It is anticipated to deliver 500 million reads per run and offer 200 and …

Full story available on

Source link

Recommended For You

About the Author: News Center